Proteinuria Trajectories: A Step Forward or Parallel Track in IgA Nephropathy Prediction?

Clin J Am Soc Nephrol

Department of Internal Medicine; The Institute of Kidney Diseases, Yonsei University College of Medicine, Seoul, South Korea.

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12262922PMC
http://dx.doi.org/10.2215/CJN.0000000756DOI Listing

Publication Analysis

Top Keywords

proteinuria trajectories
4
trajectories step
4
step forward
4
forward parallel
4
parallel track
4
track iga
4
iga nephropathy
4
nephropathy prediction?
4
proteinuria
1
step
1

Similar Publications

Longitudinal Trajectories of Albuminuria and eGFR in Type 2 Diabetes Mellitus: Natural Progression of Diabetic Kidney Disease.

J Diabetes Res

August 2025

Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

This longitudinal cohort study is aimed at examining the natural progression trajectories of diabetic kidney disease (DKD) in Type 2 diabetes mellitus (T2DM), assessing estimated glomerular filtration rate (eGFR) and albuminuria patterns over time. This longitudinal observational study analyzed 694 hospitalized patients with T2DM, featuring a cohort with a median age of 59.0 years (interquartile range [IQR] 52.

View Article and Find Full Text PDF

How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?

Nephrol Dial Transplant

August 2025

Division of Nephrology, University Health Network, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. The pathogenesis of IgAN is complex, characterized by gut mucosa-kidney interactions which lead to the production of galactose-deficient IgA1 and formation of immune complexes with anti-glycan antibodies. Both arms of the adaptive and innate immune system are implicated in modifying or amplifying inflammatory cascades which lead to disease progression.

View Article and Find Full Text PDF

Background: Despite repeating proteinuria measurements multiple times during the clinical course of a patient with CKD, clinicians may overlook the significance of temporal patterns of proteinuria. In addition, it is unclear whether proteinuria trajectories identify sub-populations with varying risks of adverse clinical outcomes.

Methods: We used group-based trajectory modeling to identify proteinuria trajectories based on annual urine protein-to-creatinine ratio (UPCR) measurements in 3209 participants of the Chronic Renal Insufficiency Cohort Study who were alive and did not reach end-stage kidney disease (ESKD) within 3 years of study entry.

View Article and Find Full Text PDF

Introduction: There are discrepant findings regarding the effect of dyslipidemia on disease progression in adult patients with chronic kidney disease (CKD).

Methods: In a prospective cohort study of children with stage 3 to 5 (predialysis) CKD, triglycerides (TGs), total cholesterol (CHOL), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured semiannually. We investigated whether CKD progression is associated with serum lipid levels at baseline and with lipid trajectories during follow-up.

View Article and Find Full Text PDF